A continuous-flow protocol for the chemoselective partial hydrogenation of α,β-unsaturated carbonyl compounds has been developed using a commercially available 1% Pd/C catalyst diluted with Celite. Cinnamaldehyde was selectively converted to hydrocinnamaldehyde in toluene at 100 °C with a liquid flow rate of 1 mL min–1 and a hydrogen flow rate of 10 mL min–1, affording yields exceeding 90% while effectively suppressing the formation of cinnamyl and hydrocinnamyl alcohols. The Pd/C packed-bed cartridge operated continuously for 168 h without any detectable loss of catalytic activity, corresponding to a turnover number of 50,300, a turnover frequency of 299 h–1, and a space-time yield of 1.64 mol Lcat–1 h–1. Substrate scope investigations revealed that methoxy-substituted cinnamaldehydes, ferulic acid, 4-phenyl-3-buten-2-one, and chalcone underwent analogous transformations, delivering the corresponding partially hydrogenated products in isolated yields ranging from 83% to quantitative. This methodology employs low catalyst loading, moderate reaction temperatures, and atmospheric hydrogen pressure, offering a cost-effective, scalable, and inherently safer alternative to conventional high-pressure batch processes for the production of fragrance and pharmaceutical intermediates. Notably, no detectable Pd leaching was observed in the product stream.
Sakurada et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: